Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Loxo Oncology Inc buy stratec

Loxo Oncology Inc
Start price
€144.77
17.05.18 / 50%
Target price
€171.38
09.01.19
Performance (%)
44.82%
End price
€209.65
09.01.19
Summary
This prediction ended on 09.01.19 with a price of €209.65. The BUY prediction by stratec for Loxo Oncology Inc saw massive gains of 44.82%. stratec has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Loxo Oncology Inc - - - -
iShares Core DAX® 0,44 % 5,90 % 8,05 % 65,58 %
iShares Nasdaq 100 1,06 % 0,92 % 28,47 % 90,18 %
iShares Nikkei 225® 1,77 % 1,23 % 47,57 % 84,99 %
iShares S&P 500 0,37 % 1,92 % 23,20 % 70,76 %

Comments by stratec for this prediction

In the thread Loxo Oncology Inc diskutieren
Prediction Buy
Perf. (%) 44.82%
Target price 171.380
Change
Ends at 09.01.19

Bayer und Loxo bei Larotrectinib auf Kurs, mit einer Übernahme, die Sinn macht!

https://seekingalpha.com/news/3357468-loxo-oncology-plus-18-percent-cancer-drug-shows-promise-early-trial

https://www.deutsche-apotheker-zeitung.de/news/artikel/2018/03/26/bayer-und-loxo-bei-larotrectinib-auf-kurs

stratec 
0
Report Share
17.05.18
Prediction Buy
Perf. (%) 44.82%
Target price 171.380
Change
Ends at 09.01.19

(Vom Mitglied beendet)

stratec 
0
Report Share
09.01.19